CoChat

Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy

Open access

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

Modeling SARS-CoV-2 in mice: Among the research tools necessary to develop medical interventions to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, high on the list are informative animal models with which to study viral pathogenesis. Gu et al. developed a mouse model in which a SARS-CoV-2 strain was infectious and could cause an inflammatory response and moderate pneumonia. Adaptation of this viral strain in the mouse appeared to be dependent on a critical amino acid change, Asn 501 to Tyr (N501Y), within the receptor-binding domain of the viral spike protein. The new mouse model was used to study neutralizing antibodies and a vaccine candidate against the virus. Science , this issue p. 1603

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.abc4730

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Generation and characterization of a mouse-adapted strain of SARS-CoV-2 in BALB/c mice. (A) Schematic diagram of the passage history of SARS-CoV-2 in BALB/c mice. The original SARS-CoV-2 viruses are shown in black, and the adapted viruses are in red. (B) SARS-CoV-2 genomic RNA loads in mouse lung homogenates at P0 to P6. Viral RNA copies were determined by means of quantitative reverse transcription polymerase chain reaction (RT-PCR). Data are presented as means ± SEM (n = 2 to 4 mice per group). (C) Tissue distribution of SARS-CoV-2 viral RNAs in mice infected with MASCp6. Groups of aged and young mice were inoculated with 1.6 × 104 PFU of MASCp6 and sacrificed at 3, 5, or 7 days after inoculation, respectively. Feces, sera, and the indicated tissue samples were collected at the specified times and subjected to viral RNA load analysis by means of quantitative RT-PCR. Dashed lines denote the detection limit. Data are presented as means ± SEM (n = 3 mice per group). (D) Multiplex immunofluorescence staining of mouse lung sections. SARS-CoV-2 S protein (green), CC10 (red), β-IV-tubulin (cyan), PDPN (magenta), SPC (gold), and nuclei (blue). The dash box is magnified at the bottom right corner of the same image. Yellow arrowheads indicate SARS-CoV-2+/CC10+ cells, redarrow heads indicate SARS-CoV-2+/CC10+/SPC+ cells, and the white arrowheads indicate SARS-CoV-2+/SPC+ cells.
Fig. 1 Generation and characterization of a mouse-adapted strain of SARS-CoV-2 in BALB/c mice. (A) Schematic diagram of the passage history of SARS-CoV-2 in BALB/c mice. The original SARS-CoV-2 viruses are shown in black, and the adapted viruses are in red. (B) SARS-CoV-2 genomic RNA loads in mouse lung homogenates at P0 to P6. Viral RNA copies were determined by means of quantitative reverse transcription polymerase chain reaction (RT-PCR). Data are presented as means ± SEM (n = 2 to 4 mice per group). (C) Tissue distribution of SARS-CoV-2 viral RNAs in mice infected with MASCp6. Groups of aged and young mice were inoculated with 1.6 × 104 PFU of MASCp6 and sacrificed at 3, 5, or 7 days after inoculation, respectively. Feces, sera, and the indicated tissue samples were collected at the specified times and subjected to viral RNA load analysis by means of quantitative RT-PCR. Dashed lines denote the detection limit. Data are presented as means ± SEM (n = 3 mice per group). (D) Multiplex immunofluorescence staining of mouse lung sections. SARS-CoV-2 S protein (green), CC10 (red), β-IV-tubulin (cyan), PDPN (magenta), SPC (gold), and nuclei (blue). The dash box is magnified at the bottom right corner of the same image. Yellow arrowheads indicate SARS-CoV-2+/CC10+ cells, redarrow heads indicate SARS-CoV-2+/CC10+/SPC+ cells, and the white arrowheads indicate SARS-CoV-2+/SPC+ cells.CC BY · PubMed Central
Fig. 2 MASCp6 infection causes pathological lung lesions and inflammatory responses in both aged and young BALB/c mice. (A) H&E staining of lung sections from aged (9 months old) BALB/c mice infected with MASCp6. Blue arrows indicate the normal areas, and yellow arrows indicate damaged areas. Data from semiquantitative analysis of histopathological changes of lung tissues are presented as means ± SEM (n = 3 mice per group). Statistical significance was analyzed by means of Mann-Whitney test. (B) Serum cytokine and chemokine heatmap in MASCp6-infected aged mice. Data are presented as fold change relative to mock infection (n = 5 mice per group). (C) H&E staining of lung sections from MASCp6-infected young mice (n = 3 mice per group). (D) Serum cytokine and chemokine heatmap in MASCp6-infected young mice (n = 5 mice per group). *P < 0.05, ***P < 0.001.
Fig. 2 MASCp6 infection causes pathological lung lesions and inflammatory responses in both aged and young BALB/c mice. (A) H&E staining of lung sections from aged (9 months old) BALB/c mice infected with MASCp6. Blue arrows indicate the normal areas, and yellow arrows indicate damaged areas. Data from semiquantitative analysis of histopathological changes of lung tissues are presented as means ± SEM (n = 3 mice per group). Statistical significance was analyzed by means of Mann-Whitney test. (B) Serum cytokine and chemokine heatmap in MASCp6-infected aged mice. Data are presented as fold change relative to mock infection (n = 5 mice per group). (C) H&E staining of lung sections from MASCp6-infected young mice (n = 3 mice per group). (D) Serum cytokine and chemokine heatmap in MASCp6-infected young mice (n = 5 mice per group). *P < 0.05, ***P < 0.001.CC BY · PubMed Central
Fig. 3 MASCp6 carries a distinct amino acid substitution in the RBD of the Spike (S) protein. (A) Schematic diagram of SARS-CoV-2 genome and all the adaptive mutations identified in MASCp6. Amino acid sequences of the parental IME-BJ05 strain and the MASCp6 strain adjacent to the N501Y mutation are shown. (B) Homology modeling of mouse ACE2 (pink) in complex with SARS-CoV-2 RBD (green) with N501 (left) or Y501 residue (right). (C) Colocalization of SARS-CoV-2 S protein (green) and mouse ACE2 (red) in the lung from SARS-CoV-2–infected mice. The dashed box in the left image is magnified in the three images at the right. (D) The proportion of A23063T mutation in each passage. The mutation threshold was defined as 1% according to the average quality score of sequenced base.
Fig. 3 MASCp6 carries a distinct amino acid substitution in the RBD of the Spike (S) protein. (A) Schematic diagram of SARS-CoV-2 genome and all the adaptive mutations identified in MASCp6. Amino acid sequences of the parental IME-BJ05 strain and the MASCp6 strain adjacent to the N501Y mutation are shown. (B) Homology modeling of mouse ACE2 (pink) in complex with SARS-CoV-2 RBD (green) with N501 (left) or Y501 residue (right). (C) Colocalization of SARS-CoV-2 S protein (green) and mouse ACE2 (red) in the lung from SARS-CoV-2–infected mice. The dashed box in the left image is magnified in the three images at the right. (D) The proportion of A23063T mutation in each passage. The mutation threshold was defined as 1% according to the average quality score of sequenced base.CC BY · PubMed Central
Fig. 4 Protection efficacy of the recombinant RBD-Fc vaccine candidate against MASCp6 challenge in mice. (A) SARS-CoV-2–specific IgG antibody titers were detected with enzyme-linked immunosorbent assay at 2 weeks after primary and boost immunization, respectively (n = 10 mice per group). Statistical significance was analyzed by means of one-way analysis of variance. (B) Neutralizing antibody titers against SARS-CoV-2 were determined with the microneutralization assay at 2 weeks after boost immunization (n = 10 mice per group). (C) Viral RNA loads in lung of vaccinated mice were detected at 5 days after MASCp6 challenge (n = 5 mice per group). Statistical significance was analyzed by means of Student’s t test. (D) Immunofluorescence staining of mouse lung sections for S protein (green) and 4′,6-diamidino-2-phenylindole (DAPI) (blue). The dotted boxes are magnified at the bottom of the same image. (E) H&E staining of mouse lung sections. Focal perivascular (green square) and peribronchiolar (yellow square) inflammation and thickened alveolar septa (blue arrow) are indicated. n.s., not significant; **P < 0.01, ***P < 0.001, ****P < 0.0001.
Fig. 4 Protection efficacy of the recombinant RBD-Fc vaccine candidate against MASCp6 challenge in mice. (A) SARS-CoV-2–specific IgG antibody titers were detected with enzyme-linked immunosorbent assay at 2 weeks after primary and boost immunization, respectively (n = 10 mice per group). Statistical significance was analyzed by means of one-way analysis of variance. (B) Neutralizing antibody titers against SARS-CoV-2 were determined with the microneutralization assay at 2 weeks after boost immunization (n = 10 mice per group). (C) Viral RNA loads in lung of vaccinated mice were detected at 5 days after MASCp6 challenge (n = 5 mice per group). Statistical significance was analyzed by means of Student’s t test. (D) Immunofluorescence staining of mouse lung sections for S protein (green) and 4′,6-diamidino-2-phenylindole (DAPI) (blue). The dotted boxes are magnified at the bottom of the same image. (E) H&E staining of mouse lung sections. Focal perivascular (green square) and peribronchiolar (yellow square) inflammation and thickened alveolar septa (blue arrow) are indicated. n.s., not significant; **P < 0.01, ***P < 0.001, ****P < 0.0001.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

Items 301–400 of 786

Metadata

Authors
Gu, H., Chen, Q., Yang, G., He, L., Fan, H., Deng, Y.-Q., Wang, Y., Teng, Y., Zhao, Z., Cui, Y., Li, Y., Li, X.-F., Li, J., Zhang, N.-N., Yang, X., Chen, S., Guo, Y., Zhao, G., Wang, X., Luo, D.-Y., Wang, H., Yang, X., Li, Y., Han, G., He, Y., Zhou, X., Geng, S., Sheng, X., Jiang, S., Sun, S., Qin, C.-F., & Zhou, Y.
Affiliations
  • Academy of Military Medical Sciences (CN)
  • Beijing Proteome Research Center (CN)
  • State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China.
  • Institute of Military Cognition and Brain Sciences, Beijing 100850, China.
  • Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
  • Beijing JOINN Biologics Co., Beijing 100176, China.
  • Shanghai Medical College of Fudan University (CN)
Corresponding author
  • Gu, Hongjing
  • Chen, Qi
  • Yang, Guan
  • He, Lei
  • Fan, Hang
  • Deng, Yong-Qiang
  • Jiang, Shibo
  • Sun, Shihui
  • Qin, Cheng-Feng
  • Zhou, Yusen
Venue
Science
Published
2020-09-25
Volume
369
Issue
6511
Pages
1603-1607
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W3045870925
Cited by
762
References
30
Citations by year
2026: 20 · 2025: 36 · 2024: 66 · 2023: 82 · 2022: 194 · 2021: 321 · 2020: 42
FWCI
21.13
Type
journal article
Language
en
Open access
Locations
  • Science (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (82041006, 82041025)
  • National Science Fund for Distinguished Young Scholars (81925025)
  • National Science and Technology Major Project of China (2018ZX09711003, 2017ZX10304402)
  • Beijing Municipal Science and Technology Project (201100001020004)
  • National Key Plan for Scientific Research and Development of China (2016YFD0500304, 2016YFD0500306, 2020YFA0707801)
  • Innovation Fund for Medical Sciences of the Chinese Academy of Medical Sciences. (2019-I2M-5-049)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords
SARS-CoV-2, BALB/c mice, vaccine efficacy, serial passage, N501Y mutation, spike protein receptor-binding domain, interstitial lung disease, aged mice, challenge model, adaptive mutation, viral virulence
MeSH terms
Immunogenicity, Vaccine, Betacoronavirus, Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, COVID-19 Vaccines, Administration, Intranasal, Animals, Disease Models, Animal, Female, Humans, Peptidyl-Dipeptidase A, Lung, Mice, Inbred BALB C, Mice, Transgenic, Mutation, Pneumonia, Viral, Vaccines, Synthetic, Viral Vaccines, Virulence, Lung Diseases, Interstitial, Coronavirus Infections, Mice, Pandemics, High-Throughput Nucleotide Sequencing, Spike Glycoprotein, Coronavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.